News & Media

March 08, 2017

Eye and Vision Care of Santa Barbara will be sponsoring its 6th Annual Golf Tournament on May 20th at Santa Barbara Golf Club!

This year the tournament will raise funds for the California Project to Cure Blindness at UCSB!

When: May 20th at 1:00-9:30

Where: The Santa Barbara Golf Club

Banquet, Silent Auction, Raffle, Putting Contest, Blind Shot Challenge, Prizes, Mulligan's, and more!

Join us to help support this important research and enjoy a day in the California sun!

November 27, 2016

Nobel-prize-winning Colombian novelist Gabriel Garcia Marquez once wrote of a mythical town in the middle of the jungle whose residents suffer from a mysterious affliction that erases their memories. Today, in a region of Colombia called Antioquia, reality appears to be imitating fiction -- in a way that may answer questions for all of us.An extended family in Colombia with a genetic mutation causing Alzheimer’s may help scientists prevent the disease someday. Lesley Stahl reports on the groundbreaking study, featuring University of California, Santa Barbara's Dr. Ken Kosik. 

November 15, 2016

The prospect of creating artery "banks" available for cardiovascular surgery, bypassing the need to harvest vessels from the patient, could transform treatment of many common heart and vascular ailments. But it's a big leap from concept to reality. The Morgridge Institute for Research and the University of Wisconsin-Madison will address both the engineering and biomedical hurdles in this process through a five-year, $8 million project funded by the National Heart, Lung and Blood Institute (NHLBI).

October 20, 2016

The cover story of the September issue of National Geographic on treating blindness featured two research projects underway at the UCSB Stem Cell Center. First mentioned was the California Project to Cure Blindness, a joint effort between USC, UCSB, Caltech, City of Hope, University College London and Regenerative Patch Technologies, where researchers are using embryonic stem cell-derived retinal pigmented epithelial cells on a scaffold to treat the dry form of age-related macular degeneration (Clegg and Coffey labs). Second, the article described work led by Henry Klassen at UC Irvine to treat retinitis pigmentosa with retinal stem cells. Both of these stem cell therapies are currently in clinical trials for ocular disease.

September 21, 2016

Age-related Macular Degeneration (AMD) affects around 15 million people in theU.S. alone, and globally up to 30 million. For most victims, vitamins and pain relief are the best treatment available.

But Professor Pete Coffey of University College London is pioneering a new therapy that could stop the disease in its tracks, and restore vision to the blind, through the London Project to Cure Blindness.

Pages